|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| Market Cap | 30.02K 25.83K 24.3K 22.2K 41.53K 2.83M 41.64K 287K 111K 1.45M 113K 110K 4.68M | P/E 2013 * |
-
| P/E 2014 | - |
|---|---|---|---|---|---|
| Enterprise Value | 30.02K 25.83K 24.3K 22.2K 41.53K 2.83M 41.64K 287K 111K 1.45M 113K 110K 4.68M | EV / Sales 2013 |
-
| EV / Sales 2014 | - |
| Free-Float |
-
| Yield 2013 * |
-
| Yield 2014 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Wanner
CEO | Chief Executive Officer | 73 | 2021-08-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.93% | +1.09% | +28.65% | +52.33% | 408.71B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.23 0 0.02 0.01 0.12 0.01 0.01 0.37 | 0.08 0.07 0.06 0.06 0.11 7.25 0.11 0.73 0.29 3.72 0.29 0.28 11.98 |
| Net income | -6.93M -5.97M -5.61M -5.13M -9.59M -655M -9.62M -66.33M -25.74M -336M -26.04M -25.47M -1.08B | -9.82M -8.45M -7.95M -7.26M -13.58M -927M -13.62M -93.91M -36.44M -476M -36.86M -36.06M -1.53B |
| Net Debt | 809K 696K 655K 598K 1.12M 76.4M 1.12M 7.74M 3M 39.2M 3.04M 2.97M 126M | 2.02M 1.74M 1.64M 1.5M 2.8M 191M 2.81M 19.35M 7.51M 97.95M 7.59M 7.43M 316M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
